β-Hhvs and hhv-8 in lymphoproliferative disorders

Mediterranean Journal of Hematology and Infectious Diseases

Volumn 3, Issue 1, 2011, Pages

  Quadrelli, C ^a   Barozzi, P ^a   Riva, G ^a   Vallerini, D ^a   Zanetti, E ^a   Potenza, L ^a   Forghieri, F ^a   Luppi, M ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84872427082     PISSN: None     EISSN: 20353006     Source Type: Journal    
DOI: 10.4084/MJHID.2011.043     Document Type: Article

References (116)

1. Comoli P and Locatelli F. T-cell therapy for the treatment of Epstein Barr virus-associated malignancies. Immunotheapy Insights http://www.la-press.com. 2009;1 3-14.
2. Caserta MT, Mock DJ, Dewhurst S. Human Herpes Virus 6. Clin Inf Dis. http://dx.doi.org/10.1086/322691 PMid:11512088. 2001; 33:829-833
3. Clark DA. Human herpes virus 6. Rev Med Virol. 2000; 10(3): 155-73. http://dx.doi.org/10.1002/(SICI)1099-1654(200005/06)10:3<155::AID-RMV277>3.0.CO;2-6
4. Santoro F, Kennedy PE, Locatelli G, Malnati MS, Berger EA, Lusso P. CD46 is a cellular receptor for human herpesvirus 6. Cell. 1999;99(7):817-27. http://dx.doi.org/10.1016/S0092-8674(00)81678-5
5. Ward KN, Leong HN, Nacheva EP, Howard J, Atkinson CE, Davies NW, Griffiths PD, Clark DA. Human herpesvirus 6 chromosomal integration in immunocompetent patients results in high levels of viral DNA in blood, sera, and hair follicles. J Clin Microbiol. 2006; 44: 1571-1574. http://dx.doi.org/10.1128/JCM.44.4.1571-1574.2006 PMid:16597897 PMCid:1448653
6. Potenza L, Barozzi P, Masetti M; Pecorari M, Bresciani P, Gautheret-Dejean A, Riva G, Vallerini D, Tagliazucchi S, Codeluppi M, Di Benedetto F, Gerunda GE, Narni F, Torelli G, Luppi M. Prevalence of human herpesvirus-6 chromosomal integration (CIHHV-6) in Italian solid organ and allogeneic stem cell transplant patients. Am J Transplant. 2009; 9:1-8. http://dx.doi.org/10.1111/j.1600-6143.2009.02685.x PMid:19519818
7. Torelli G, Barozzi P, Marasca R, Cocconcelli P, Merelli E, Ceccherini-Nelli L, Ferrari S, Luppi M. Targeted integration of human herpesvirus 6 in the p arm of chromosome 17 of human peripheral blood mononuclear cells in vivo. J Med Virol. 1995;46(3): 178-88. http://dx.doi.org/10.1002/jmv.1890460303 PMid:7561787
8. Morris C, Luppi M, McDonald M, Barozzi P, Torelli G. Fine mapping of an apparently targeted latent human herpesvirus type 6 integration site in chromosome band 17p13.3. J Med Virol. 1999;58(1):69-75. http://dx.doi.org/10.1002/(SICI)1096-9071(199905)58:1<69::AID-JMV11>3.0.CO;2-3
9. Daibata Taguchi T, Taguchi H, Miyoshi I. Integration of human herpesvirus 6 in a Burkitt's lymphoma cell line. Br J Haematol. 1998;102(5):1307-13. PMid:9753061
10. Daibata M, Taguchi T, Nemoto Y, Taguchi H, Miyoshi I. Inheritance of chromosomally integrated human herpesvirus 6 DNA. Blood. 1999; 1; 94(5): 1545-9.
11. Puri RK, Leland P, Razzaque A. Antigen(s)-specific tumour infiltrating lymphocytes from tumour induced by fhuman herpesvirus-6 (HHV-6) DNA transfected NIH 3T3 transformants. Clin Exp Immunol.199; 83:96-101.
12. OgataM, Satou T, Kawano R, Takakura S, Goto K, Ikewaki J, Kohno K, Ikebe T, Ando T, Miyazaki Y, Ohtsuka E, Saburi Y, Saikawa T, Kadota J. Correlations of HHV-6 viral load and plasma IL-6 concentration with HHV-6 encephalitis in allogeneic stem cell transplant recipients. Bone Marrow Transplant. 2009; 45:129-136. http://dx.doi.org/10.1038/bmt.2009.116 PMid:19465942
13. Razzaque A. Oncogenic potential of human herpesvirus-6 DNA. Oncogene. 1990; 5:1365-1370. PMid:2170897
14. Razzaque A, Williams O, Wang J, Rhim JS. Neoplastic transformation of immortalized human epidermal keratinocytes by two HHV-6 DNA clones. Virology. 1993; 195:113-120. http://dx.doi.org/10.1006/viro.1993.1351 PMid:8391179
15. Kashanchi F, Araujo J, Doniger J, Muralidhar S, Hoch R, Khleif S, Mendelson E, Thompson J, Azumi N, Brady JN, Luppi M, Torelli G, Rosenthal LJ. 1997. Human herpesvirus 6 (HHV-6) ORF-1 transactivating gene exhibits malignant transforming activity and its protein binds to p53. Oncogene 14:359-367. http://dx.doi.org/10.1038/sj.onc.1200840 PMid:9018122
16. Doniger J, Muralidhar S, Rosenthal LJ. Human cytomegalovirus and human herpesvirus 6 genes that transform and transactivate. Clin Microbiol Rev. 1999; 12:367-382. PMid:10398670 PMCid:100243
17. Takemoto M, Shimamoto T, Isegawa Y, Yamanishi K. The R3 region, one of three major repetitive regions of human herpesvirus 6, is a strong enhancer of immediate-early gene U95. J Virol. 2001; 75:10149-10160. http://dx.doi.org/10.1128/JVI.75.21.10149-10160.2001 PMid:11581383 PMCid:114589
18. Campbell KJ, Perkins ND. Regulation of NF-kappaB function. Biochem Soc Symp. 2006; 73:165-180. PMid:16626297
19. Torelli G, Marasca R, Luppi M, Selleri L, Ferrari S, Narni F, Mariano MT, Federico M, Ceccherini-Nelli L, Bendinelli M, Montagnani G, Montorsi M, Artusi T. Human herpesvirus-6 in human lymphomas: Identification of specific sequences in Hodgkin's lymphomas by polymerase chain reaction. Blood. 1991; 77:2251-2258. PMid:1674220
20. Krueger GR, Huetter ML, Rojo J, Romero M, Cruz-Ortiz H. Human herpesviruses HHV-4 (EBV) and HHV-6 in Hodgkin's and Kikuchi's diseases and their relation to proliferation and apoptosis. Anticancer Res. 2001; 21:2155-2161 PMid:11501840
21. Lacroix A, Jaccard A, Rouzioux C, Piguet C, Petit B, Bordessoule D, Ranger-Rogez S. HHV-6 and EBV DNA quantitation in lymph nodes of 86 patients with Hodgkin's lymphoma. J Med Virol. 2007; 79:1349-1356. http://dx.doi.org/10.1002/jmv.20868 PMid:17607791
22. Luppi M, Barozzi P, Garber R, Maiorana A, Bonacorsi G, Artusi T, Trovato R, Marasca R, Torelli G. Expression of human herpesvirus-6 antigens in benign and malignant lymphoproliferative diseases. Am J Pathol. 1998; 153:815-823. http://dx.doi.org/10.1016/S0002-9440(10)65623-4
23. Lacroix A, Collot-teixeira S, Mardivirin L, Jaccard A, Petit B, Piguet C, Sturtz F, Preux PM, Bordeussoule D, Ranger-Rogez S. Involvement of Human Herpesvirus-6 Variant B in classic Hodgking's Lymphoma via DR7 oncoprotein. Clin Cancer Res. 2010; 16:4711-4721. http://dx.doi.org/10.1158/1078-0432.CCR-10-0470 PMid:20858841
24. Luppi M, Marasca R, Barozzi P, Artusi T, Torelli G. Frequent detection of human herpesvirus-6 sequences by polymerase chain reaction in paraffin-embedded lymph nodes from patients with angioimmunoblastic lymphadenopathy and angioimmunoblastic lymphadenopathy-like lymphoma. Leuk Res. 1993;.17:1003-1011.
25. Zhou Y, Attygalle AD, Chuang SS, Diss T, Ye H, Liu H, Hamoudi RA, Munson P, Bacon CM, DoganA, Du MQ. Angioimmunoblastic T-cell lymphoma: Histological progression associates withEBVand HHV6B viral load. Br J Haematol. 2007; 138:44-53. http://dx.doi.org/10.1111/j.1365-2141.2007.06620.x PMid:17555446
26. Ojima T, Abe K, Ohyashiki JH, Shirakata M, Yamamoto K. IL-2-regulated persistent human herpesvirus-6 B infection facilitates growth of adult T cell leukemia cells. J Med Dent Sci. 2005; 52:135-141. PMid:16187619
27. Levine PH, Ablashi DV, Saxinger WC, Connelly RR. Antibodies to human herpes virus-6 in patients with acute lymphocytic leukemia. Leukemia. 1992a 6:1229-1231. PMid:1331626
28. Salonen MJ, Siimes MA, Salonen EM, Vaheri A, Koskiniemi M. Antibody status to HHV-6 in children with leukaemia. Leukemia. 2002;16:716-719. http://dx.doi.org/10.1038/sj.leu.2402437 PMid:11960354
29. Barozzi P, Luppi M, Marasca R, Trovato R, Ceccherini-Nelli L, Torelli G. Human herpesvirus-6 genome in acute lymphoblastic leukemia: Evidence against an etiologic relationship. Acta Haematol. 1995; 94:169-172 http://dx.doi.org/10.1159/000204004 PMid:7502638
30. Steininger C, Rassenti LZ, Vanura K, Eigenberger K, Jager U, Kipps TJ, Mannhalter C, Stilgenbauer S, Popow-Kraupp T. Relative seroprevalence of human herpes viruses in patients with chronic lymphocytic leukaemia. Eur J Clin Invest. 2009; 39:497-506. http://dx.doi.org/10.1111/j.1365-2362.2009.02131.x PMid:19490058
31. Akashi K, Eizuru Y, Sumiyoshi Y, Minematsu T, Hara S, Harada M, Kikuchi M, Niho Y, Minamishima Y. Brief report: Severe infectious mononucleosis-like syndrome and primary human herpesvirus 6 infection in an adult. N Engl J Med. 1993; 329:168-171. http://dx.doi.org/10.1056/NEJM199307153290304 PMid:8390615
32. Maric I, Bryant R, Abu-Asab M, Cohen JI, Vivero A, Jaffe ES, Raffeld M, Tsokos M, Banks PM, Pittaluga S. Human herpesvirus-6-associated acute lymphadenitis in immunocompetent adults. Mod Pathol.2004;17:1427-1433 http://dx.doi.org/10.1038/modpathol.3800179 PMid:15494709 PMCid:2288737
33. Levine PH, Jahan N, Murari P, ManakM, Jaffe ES. Detection of human herpesvirus 6 in tissues involved by sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease). J Infect Dis. 1992;166:291-295. http://dx.doi.org/10.1093/infdis/166.2.291 PMid:1321861
34. Arbeitskreis Blut, Untergruppe "Bewertung Blutassoziierter Krankheitserreger". Human Cytomegalovirus (HCMV). Transfus Med Hemother. 2010; 37: 365-375. http://dx.doi.org/10.1159/000322141 PMid:21483467 PMCid:3048947
35. Boeckh M and Geballe AP. Cytomegalovirus: pathogen, paradigm, and puzzle. J Clin Invest. 2011. 121(5). 1673-80. http://dx.doi.org/10.1172/JCI45449 PMid:21659716
36. Sinzger C, Digel M, Jahn G. Cytomegalovirus cell tropism. Curr Top Microbiol Immunol. 2008;325:63-83. http://dx.doi.org/10.1007/978-3-540-77349-8_4
37. Rodríguez-Caballero A, García-Montero AC, Bárcena P, Almeida J, Ruiz-Cabello F, Tabernero MD, Garrido P, Muñoz-Criado S, Sandberg Y, Langerak AW, González M, Balanzategui A, Orfao A. Expanded cells in monoclonal TCR alphabeta+/CD4+/NKa+/CD8-/+dim T-LGL lymphocytosis recognize hCMV antigens. Blood. 2008;112(12):4609-16. http://dx.doi.org/10.1182/blood-2008-03-146241 PMid:18768393
38. Lennette ET, Blackbourn DJ, Levy JA. Antibodies to human herpesvirus type 8 in the general population and in Kaposi's sarcoma patients. Lancet 1996;348:858-61. http://dx.doi.org/10.1016/S0140-6736(96)03240-0
39. Whitby D, Luppi M, Barozzi P, Boshoff C, Weiss RA, Torelli G. Human herpesvirus 8 seroprevalence in blood donors and lymphoma patients from different regions of Italy. J Natl Cancer Inst 1998;90:395-7. http://dx.doi.org/10.1093/jnci/90.5.395
40. Simpson GR, Schulz TF, Whitby D, et al. Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen. Lancet 1996; 348:1133-8 http://dx.doi.org/10.1016/S0140-6736(96)07560-5
41. Damania B. Oncogenic γ-herpesviruses: comparison of viral proteins involved in tumorigenesis. Nat Rev Microbiol. 2004; 2: 656-667. http://dx.doi.org/10.1038/nrmicro958 PMid:15263900
42. Carbone A and Gaidano G. HHV-8 positive body-cavity-based lymphoma: a novel lymphoma entity Br J Haematol. 1997; 97: 515-22. http://dx.doi.org/10.1046/j.1365-2141.1997.00064.x PMid:9207392
43. Harris NL, Jaffe ES, Diebold J, Flandrin G, Muller-Hermelink K, Vardiman J, Lister TA, Bloomfield CD. World Health Organization Classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the clinical advisory committee meeting-Airlie House, Virginia, November 1997. J Clin Oncol. 1999; 17: 3835-49. PMid:10577857
44. Simonelli C, Spina M, Cinelli R, Talamini R, Tedeschi R, Gloghini A, Vaccher E, Carbone A, Tirelli U. Clinical features and outcome of primary effusion lymphoma in HIV-infected patients: a single-institution study. J Clin Oncol. 2003; 21: 3948-http://dx.doi.org/10.1200/JCO.2003.06.013 PMid:14581418
45. Cesarman E, Chang Y, Moore PS, Said JW, Knowles DM. Kaposi' sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. New Engl J Med. 1995; 332: 1186-91. http://dx.doi.org/10.1056/NEJM199505043321802 PMid:7700311
46. Nador RG, Cesarman E, Chadburn A, Dawson DB, Ansari MQ, Said J, Knowles DM. Primary effusion lymphoma: a distinct clinico-pathologic entity associated with the Kaposi's sarcomaassociated herpesvirus. Blood. 1996; 88: 645-56. PMid:8695812
47. Komanduri KVJ, Luce JA, McGrath MS, Herndier BG, Ng VL. The natural history and molecular heterogeneity of HIVassociated primary malignant lymphomatous effusions. J Acquir Immun Defic. 1996; 13: 215-26. http://dx.doi.org/10.1097/00042560-199611010-00003 PMid:8898666
48. Ariad S, Benharroch D, Lupu L, Davidovici B, Dupin N, Boshoff C. Early peripheral lymph node involvement of human herpesvirus 8-associated body cavity-based lymphoma in a human immunodeficiency virus-negative patient. Arch Pathol Lab Med. 2000; 124: 753-5. PMid:10782162
49. Boshoff C, Gao S-J, Healy LE, Matthews S, Thomas AJ, Coignet L, Warnke RA, Strauchen JA, Matutes E, Kamel OW, Moore PS, Weiss RA, Chang Y. Establishing a KSHV+ cell line (BCP-1) from peripheral blood and characterizing its growth in Nod/SCID mice. Blood. 1998; 91: 1671-9. PMid:9473233
50. Dotti, G., Fiocchi, R., Motta, T., Facchinetti, B., Chiodini, B., Boleri, G.M., Gavazzeni, G., Barbui, T., Rambaldi, S. Primary effusion lymphoma after heart transplantation: a new entity associated with human herpesvirus-8. Leukemia. 1999; 13: 664-http://dx.doi.org/10.1038/sj.leu.2401390 PMid:10374868
51. DePond W, Said JW, Tasaka T, de Vos S, Kahn D, Cesarman E, Knowles DM, Koeffler HP. Kaposi's sarcoma-associated herpesvirus and human herpesvirus 8 (KSHV/HHV-8)-associated lymphoma of the bowel. Am J Surg Pathol. 1997; 21: 719-24. http://dx.doi.org/10.1097/00000478-199706000-00013 PMid:9199651
52. Drexler HG, Huphoff CC, Gaidano G, Carbone A. Lymphoma cell lines: in vitro models for the study of HHV-8 + primary effusion lymphomas (body-cavity based lymphomas). Leukemia. 1998; 12: 1507-17. http://dx.doi.org/10.1038/sj.leu.2401160 PMid:9766492
53. Jaffe E. Primary body cavity-based AIDS-related lymphomas. Evolution of a new disease entity. Am J Clin Pathol. 1996; 105: 141-3 PMid:8607435
54. Carbone A. Emerging pathways in the development of AIDSrelated lymphomas. The Lancet Oncology. 2003; 4: 22-9. http://dx.doi.org/10.1016/S1470-2045(03)00957-4
55. Klein U, Gloghini A, Gaidano G, Chadburn A, Cesarman E, Dalla-Favera R, Carbone A. Gene expression profile analysis of AIDS-related primary effusion lymphoma (PEL) suggests a plasmablastic derivation and identifies PEL-specific transcripts. Blood. 2003; 101: 4115-21. http://dx.doi.org/10.1182/blood-2002-10-3090 PMid:12531789
56. Fais F, Gaidano G, Capello D, Gloghini A, Ghiotto F, Roncella S, Carbone A, Chiorazzi N, Ferrarini M. Immunoglobulin V region gene use and structure suggest antigen selection in AIDSrelated primary effusion lymphomas. Leukemia. 1999; 13: 1093-PMid:10400426
57. Judde J-G, Lacoste V, Brière J, Kassa-Kelembho E, Clyti E, Couppiè P, Buchrieser C, Tulliez M, Morvan J, Gessain A. Monoclonality or oligoclonality of human herpesvirus 8 terminal repeat sequences in Kaposi's sarcoma and other diseases. J Natl Canc Inst. 2000; 22: 729-36. http://dx.doi.org/10.1093/jnci/92.9.729 PMid:10793109
58. Jones KD, Aoki Y, Chang Y, Moore PS, Yarchoan R, Tosato G. Involvement of interleukin-10 (IL-10) and viral IL-6 in the spontaneous growth of Kaposi's sarcoma herpesvirus-associated infected primary effusion lymphoma cells. Blood. 1999; 94: 2871-79. PMid:10515891
59. Aoki Y, Jaffe ES, Chang Y, Jones K, Teruya-Feldstein J, Moore PS, Tosato G. Angiogenesis and hematopoiesis induced by Kaposi's sarcoma-associated herpesvirus-encoded interleukin-6. Blood. 1999; 93: 4034-43. PMid:10361100
60. Aoki Y, Tosato G. Role of vascular endothelial growth factor/vascular permeability factor in the pathogenesis of Kaposi sarcoma-associated herpesvirus-infected primary effusion lymphomas. Blood. 1999; 94: 4247-54. PMid:10590069
61. Jones D, Ballestas M.E, Kaye K.M, Gulizia J.M, Winters G.L, Fletcher J, Scadden D.T, Aster J.C. Primary effusion lymphoma and Kaposi's sarcoma in a cardiac-transplant recipient. N Engl J Med. 1998; 339: 444-9. http://dx.doi.org/10.1056/NEJM199808133390705 PMid:9700178
62. Shaw RN, Waller EK, Offermann MK. Induction of human herpesvirus 8 gene expression in a post-transplantation primary effusion lymphoma cell line. Leuk Lymphoma. 2002; 43: 631-4. http://dx.doi.org/10.1080/10428190290012173
63. Strauchen JA, Hauser D, Burstein D, Jimenez R, Moore PS, Chang Y. Body-cavity-based malignant lymphoma containing Kaposi sarcoma-associated herpesvirus in an HIV-negative man with previous Kaposi sarcoma. Ann Intern Med. 1996; 125: 822-PMid:8928989
64. Ascoli V, Lo Coco F, Torelli G, Vallisa D, Cavanna L, Bergonzi C, Luppi M. Human herpesvirus 8-associated primayi effusion lymphoma in HIV-patients: a clinico epidemiologic variant resembling classic Kaposi's sarcoma. Haematologica. 2002; 87: 339-43. PMid:11940475
65. Simonelli C, Tedeschi R, Gloghini A, Bortolin MT, Spina M, Bidoli E, Cinelli R, De Paoli P, Carbone A, Tirelli U. Characterization of immunologic and virological parameters in HIV-infected patients with primary effusion lymphoma during antiblastic therapy and highly active antiretroviral therapy. Clin Infect Dis. 2005; 40: 1022-7. http://dx.doi.org/10.1086/428615 PMid:15824995
66. Lee RK, Cai J-P, Deyev V, Gill PS, Cabral L, Wood C, Agarwal RP, Xia W, Boise LH, Podack E, Harrington Jr WJ. Azidothymidine and interferon-α induce apoptosis in herpesvirus-associated lymphomas. Cancer Res. 1999; 59: 5514-PMid:10554028
67. Ghosh SK, Wood C, Boise LH, Mian AM, Deyev VV, Feuer G, Toomey NL, Shank NC, Cabral L, Barber GN, Harrington WJ Jr. Potentiation of TRAIL-induced apoptosis in primary effusion lymphoma through azidothymidine-mediated inhibition of NFkappa B. Blood. 2003; 101: 2321-7. http://dx.doi.org/10.1182/blood-2002-08-2525 PMid:12406882
68. Oksenhendler E, Clauvel JB, Jouveshomme S, Davi F, Mansour G. Complete remission of a primary effusion lymphoma with antiretroviral therapy. Am J Hematol. 1998; 57: 266 http://dx.doi.org/10.1002/(SICI)1096-8652(199803)57:3<266::AID-AJH25>3.0.CO;2-7
69. Luppi M, Trovato R, Barozzi P, Vallisa D, Rossi G, Re A, Ravazzini L, Potenza L, Riva G, Morselli M, Longo G, Cavanna L, Roncaglia R, Torelli G. Treatment of herpesvirus associated primary effusion lymphoma with intracavity cidofovir. Leukemia. 2005; 19: 473-6. http://dx.doi.org/10.1038/sj.leu.2403646 PMid:15674353
70. Halfdanarson TR, Markovic SN, Kalokhe U, Luppi M. A nonchemotherapy treatment of a primary effusion lymphoma: durable remission after intracavitary cidofovir in HIV negative PEL refractory to chemotherapy. Ann Oncol. 2006;17(12):1849-http://dx.doi.org/10.1093/annonc/mdl139 PMid:16766593
71. Curreli F, Friedman-Kien AE, Flore O. Glycyrrhizic acid alters Kaposi sarcoma-associated herpesvirus latency, triggering p53-mediated apoptosis in transformed B lymphocytes. J Clin Invest 2005; 115: 642-52. PMid:15765147 PMCid:1051998
72. Cohen JI. Licking latency with licorice. J Clin Invest. 2005; 115: 591-3. PMid:15765143 PMCid:1052015
73. Klass CM and Offermann MK. Targeting human herpesvirus-8 for the treatment of Kaposi's sarcoma and primary effusion lymphoma. Curr Opin Oncol. 2005; 17: 447-55. http://dx.doi.org/10.1097/01.cco.0000172823.01190.6c PMid:16093794
74. Peterson BA & Frizzera G. Multicentric Castleman's disease. Semin Oncol. 1993; 20: 636-47 PMid:8296200
75. Soulier J, Grollet L, Oksenhendler E, Cacoub P, Cazals-Hatem D, Babinet P, d'Agay M-F, Clauvel J-P, Raphael M, Degos L, Sigaux F. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease. Blood. 1995; 86: 1276-80. PMid:7632932
76. Gessain A, Sudaka A, Brière J, Fouchard N, Nicola M-A, Rio B, Arborio M, Troussard X, Audouin J, Diebold J, de Thè G. Blood. 1996; 87: 414-6. PMid:8547672
77. Corbellino M, Poirel L, Aubin JT, Paulli M, Magrini U, Bestetti G, Galli M, Parravicini C. The role of human herpesvirus 8 and Epstein-Barr virus in the pathogenesis of giant lymph node hyperplasia (Castleman's disease). Clin Infect Dis. 1996; 22: 1120-1. http://dx.doi.org/10.1093/clinids/22.6.1120 PMid:8783733
78. Barozzi P, Luppi M, Masini L, Marasca R, Savarino M, Morselli M, Ferrari MG, Bevini M, Bonacorsi G, Torelli G. Lymphotropic herpes virus (EBV, HHV-6, HHV-8) DNA sequences in HIV negative Castleman's disease. J Clin Pathol Mol Pathol. 1996; 49: M232-5. http://dx.doi.org/10.1136/mp.49.4.M232
79. Bèlec L, Mohamed AS, Authier F-J, Hallouin M-C, Soe AM, Cotigny S, Gaulard P, Gherardi RK. Human herpesvirus 8 infection in patients with POEMS syndrome-associated multicentric Castleman's disease. Blood. 1999; 93: 3643-3653. PMid:10339470
80. Parravicini C, Olsen SJ, Capra M, Poli F, Sirchia G, Gao SJ, Berti E, Nocera A, Rossi E, Bestetti G, Pizzuto M, Galli M, Moroni M, Moore PS, Corbellino M. Risk of Kaposi's sarcomaassociated herpesvirus transmission from donor allografts among Italian post-transplant Kaposi's sarcoma patients. Blood. 1997; 90: 2826-9. PMid:9326251
81. Dupin N, Fisher C, Kellam P, Ariad S, Tulliez M, Franck N, Van Marck E, Salmon D, Gorin I, Escande J-P, Weiss RA, Alitalo K, Boshoff C. Distribution of human herpesvirus-8 latently infected cells in Kaposi's sarcoma, multicentric Castleman's disease, and primary effusion lymphoma. Proc Natl Acad Sci. 1999; 96: 4546-51. http://dx.doi.org/10.1073/pnas.96.8.4546
82. Dupin N, Diss TL, Kellam P, Tulliez M, Du M-Q, Sicard D, Weiss RA, Isaacson PG, Boshoff C. HHV-8 is associated with a plasmablastic variant of Castleman disease that is linked to HHV-8-positive plasmablastic lymphoma. Blood. 2000; 95: 1406-12. PMid:10666218
83. Du MQ, Liu H, Diss TC, Ye H, Hamoudi RA, Dupin N, Meignin V, Oksehendler E, Boshoff C, Isaacson PG. Kaposi sarcomaassociated herpesvirus infects monotypic (IgM lambda) but polyclonal naive B cells in Castleman disease and associated lymphoproliferative disorders. Blood. 2001; 97: 2130-6. http://dx.doi.org/10.1182/blood. V97.7.2130 PMid:11264181
84. Oksenhendler E, Boulanger E, Galicier L, Du M-Q, Dupin N, Diss TC, Hamoudi R, Daniel M-T, Agbalika F, Boshoff C, Clauvel J-P, Isaacson PG, Meignin V. High incidence of Kaposi sarcoma-associated herpesvirus-related non-Hodgkin lymphoma in patients with HIV infection and multicentric Castleman disease. Blood. 2002; 100: 3415-8. PMid:12384445
85. Parravicini C, Corbellino M, Paulli M, Magrini U, Lazzarino M, Moore PS, Chang Y. Expression of a virus-derived cytokine, KSHV vIL-6 in HIV sieronegative Castleman's disease. Am J pathol. 1997; 6: 1517-22.
86. Parravicini C, Chandran B, Corbellino M, Berti E, Paulli M, Moore PS, Chang Y. Differential viral protein expression in Kaposi's sarcoma Am J Pathol. 2000; 156: 743-9. http://dx.doi.org/10.1016/S0002-9440(10)64940-1
87. Staskus KA, Sun R, Miller G, Racz P, Jaslowski A, Metroka C, Brett-Smith H, Haase AT. Cellular tropism and viral interleukin-6 expression distinguish human herpesvirus 8 involvement in Kaposi' sarcoma, primary effusion lymphoma, and Castleman's disease. J Virol. 1999; 73: 4181-7. PMid:10196314 PMCid:104197
88. Luppi M, Barozzi P, Maiorana A, Trovato R, Marasca R, Morselli M, Cagossi K, Torelli G. Expression of cellhomologous genes of human herpesvirus-8 in human immunodeficiency virus-negative lymphoproliferative diseases. Blood. 1999; 94: 2931-3. PMid:10515899
89. Grandadam MJ, Gorin I, Blum L, Kernbaum S, Sicard D, Buisson Y, Agut H, Escande JB, Huraux JM. Exacerbations of clinical symptoms in human immunodeficiency virus type-1 infected patients with multicentric Castleman's disease are associated with a high increase in Kaposi's sarcoma herpesvirus DNA load in peripheral blood mononuclear cells. J Infect Dis.1997; 175: 1198-201. http://dx.doi.org/10.1086/593567 PMid:9129085
90. Oksenhendler E, Carcelain G, Aoki Y, Boulanger E, Maillard A, Clauvel J-P, Agbalika F. High levels of human herpesvirus 8 viral load, human interleukin-6, interleukin-10, and C reactive protein correlate with exacerbation of multicentric Castleman disease in HIV-infected patients. Blood. 2000; 96: 2069-73. PMid:10979949
91. Oksenhendler E, Cacoub P, Welker Y, Cadranel J, Cazals-Hatem D, Autran B, Clauvel JP, Raphael M. Multicentric Castleman disease in HIV infection: a clinical and pathological study of 20 patients. AIDS. 1996; 10: 61-7. http://dx.doi.org/10.1097/00002030-199601000-00009 PMid:8924253
92. Rieu P, Droz D, Gessain A, Grunfeld JB, Hermine O. Retinoic acid for treatment of multicentric Castleman disease. Lancet. 1999; 354: 1262-3. http://dx.doi.org/10.1016/S0140-6736(99)03957-4
93. Casper C, Nicholas G, Huang M-L, Corey L, Wald A. Remission of HHV-8 and HIV-associated multicentric Castleman disease with ganciclovir treatment. Blood. 2004; 103: 1632-4. http://dx.doi.org/10.1182/blood-2003-05-1721 PMid:14615380
94. Nishimoto N, Kanakura Y, Aozasa K, Johkoh T, Nakamura M, Nakano S, Nakano N, Ikeda Y, Sasaki T, Asaoku H, Kumagai S, Kodama F, Nakahara H, Hagihara K, Yoshizaki K, Kishimoto T. Humanized anti-interleukin receptor antibody treatment of multicentric Castleman disease. Blood. 2005; 106: 2627-32. http://dx.doi.org/10.1182/blood-2004-12-4602 PMid:15998837
95. Rettig MB, Ma HJ, Vescio RA, Pold M, Schiller G, Belson D, Savage A, Nishikubo C, Wu C, Fraser J, Said JW, Berenson JR. Kaposi's sarcoma-associated herpesvirus infection of bone marrow dendritic cells from multiple myeloma patients. Science. 1997; 276: 1851-4. http://dx.doi.org/10.1126/science.276.5320.1851 PMid:9188529
96. Yi O, Ekman M, Anton D, Bergenbrant S, Osterborg A, Goergii-Hemming P, Holm G, Nilsson K, Bibefeld P. Blood dendritic cells from myeloma patients are not infected with Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8). Blood. 1998; 92: 402-4. PMid:9657737
97. Tarte K, Chang Y, Klein B. Kaposi's sarcoma-associated herpesvirus and multiple myeloma: lack of criteria for causality. Blood. 1999; 93: 3159-63. PMid:10233868
98. Ablashi DV, Chatlynne L, Thomas D, Bourboulia D, Rettig MB, Vescio RA, Viza D, Gill P, Kyle RA, Berenson JR, Whitman JE. Lack of serologic association of human herpesvrus-8 (KSHV) in patients with monoclonal gammopathy of undetermined significance with and without progression to multiple myeloma. Blood. 2000; 96: 2304. PMid:10979981
99. Carbone A, Gloghini A, Vaccher E, Cerri M, Gaidano G, Dalla-Favera R, Tirelli U. Kaposi's sarcoma-associated herpesvirus/human herspesvirus 8-positive solid lymphomas. A tissue-based variant of primary effusion lymphomas. J Mol Diagn. 2005; 7: 17-27. http://dx.doi.org/10.1016/S1525-1578(10)60004-9
100. Hermouet S, Corre I, Gassin M, Bigot-Corbel E, Sutton CA, Casey JW. Hepatitis C virus, human herpesvirus 8, and the development of plasma cell leukemia. New Engl J Med. 2003; 348: 178-9. http://dx.doi.org/10.1056/NEJM200301093480219 PMid:12519936
101. Du MQ, Diss TC, Liu H, Ye H, Hamoudi RA, Cabecadas J, Dong HY, Harris NL, Chan JK, Rees JW, Dogan A, Isaacson PG. KSHV- and EBV-associated germinotropic lymphoproliferative disorder. Blood. 2002; 100: 3415-8. http://dx.doi.org/10.1182/blood-2002-02-0487 PMid:12384445
102. Wheat WH, Cool CD, Morimoto Y, Rai PR, Kirkpatrick CH, Lindenbaum BA, Bates CA, Ellison MC, Seris AE, Brown KK, Routes JM. Possible role of human herpesvirus 8 in the lymphoproliferative disorders in common variable immunodeficiency. J Exp Med. 2005; 202: 479-84. http://dx.doi.org/10.1084/jem.20050381 PMid:16103407 PMCid:2212861
103. Luppi M, Barozzi P, Marasca R, Savarino M, Torelli G. HHV-8-associated primary cerebral B-cell lymphoma in HIV-negative patient after long term steroids. The Lancet.1996; 347: 980. http://dx.doi.org/10.1016/S0140-6736(96)91473-7
104. Kapelushnik, J., Ariad, S., Benharroch, D., Landau, D., Moser, A., Delsol, G., Brousset, P. Post renal transplantation human herpesvirus 8-associated lymphoproliferative disorder and Kaposi's sarcoma. Br J Haematol. 2001; 113: 425-8. http://dx.doi.org/10.1046/j.1365-2141.2001.02740.x PMid:11380409
105. Matsushima, A.Y., Strauchen, J.A., Lee, G., Scigliano, E., Hale, E.E., Weisse, M.T., Burstein, D., Kamel, O., Moore, P.S., Chang, Y. Posttransplantation plasmacytic proliferations related to Kaposi's sarcoma-associated herpesvirus. Am J Surg Pathol. 1999; 23: 1393-1400. http://dx.doi.org/10.1097/00000478-199911000-00010 PMid:10555008
106. Luppi, M., Barozzi, P., Maiorana, A., Artusi, T., Trovato, R., Marasca, R., Savarino, M., Ceccherini-Nelli, L., Torelli, G. Human herpesvirus-8 DNA sequences in human immunodeficiency virus-negative angioimmunoblastic lymphadenopathy and benign lymphadenopathy with giant germinal center hyperplasia and increased vascularity. Blood. 1996; 87: 3903-9. PMid:8611719
107. Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, Knowles DM, Moore PS. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science. 1994; 266: 1865-9. http://dx.doi.org/10.1126/science.7997879 PMid:7997879
108. Oksenhendler, E., Cazals-Hatem, D., Schulz, T.F., Barateau, V., Grollet, L., Sheldon, J., Clauvel, J.P., Sigaux, F., Agbalika, F. Transient angiolymphoid hyperplasia and Kaposi's sarcoma after primary infection with human herpesvirus 8 in a patient with human immunodeficiency virus infection. N Engl J Med. 1998; 338: 1585-90. http://dx.doi.org/10.1056/NEJM199805283382204 PMid:9603796
109. Wong SW, Bergquam EP, Swanson RM, Lee FW, Shiigi SM, Avery NA, Fanton JW, Axthelm MK. Induction of B cell hyperplasia in simian immunodeficiency virus-infected Rhesus macaques with the simian homologue of Kaposi's sarcomaassociated herpesvirus. J Exp Med.1999; 190: 827-40. http://dx.doi.org/10.1084/jem.190.6.827 PMid:10499921 PMCid:2195633
110. Luppi M and Torelli G. Human herpesvirus 8 and interstitial pneumonitis in an HIV-negative patient. New Engl J Med 1996; 335: 351-2. http://dx.doi.org/10.1056/NEJM199608013350514 PMid:8668220
111. Muller A, Franzen C, Klussmann P, Wagner M, Diehl V, Fatkenhenen G, Salzberger B, Ablashi DV, Krueger GR. Human herpesvirus type 8 in HIV infected patients with interstitial pneumonitis. J Infect Dis. 2000; 40: 242-7.
112. Luppi M, Barozzi P, Schulz TF, Trovato R, Donelli A, Narni F, Sheldon J, Marasca R, Torelli G. Non malignant disease associated with human herpesvirus 8 reactivation in patients who have undergone autologous peripheral blood stem cell transplantation. Blood. 2000; 96: 2355-7. PMid:11001882
113. Luppi M, Barozzi P, Schulz TF, Setti G, Staskus K, Trovato R, Narni F, Donelli A, Maiorana A, Marasca R, Sandrini S, Torelli G. Bone marrow failure associated with human herpesvirus 8 infection after transplantation. New Engl J Med. 2000; 343: 1378-85. http://dx.doi.org/10.1056/NEJM200011093431905 PMid:11070102
114. Luppi M, Trovato R, Barozzi P, Gibellini F, Potenza L, Riva G, Torelli G. Suppressive effect of human herpesvirus-8/Kaposi sarcoma-associated herpesvirus on in vitro colony formation of hematopoietic progenitor cells. Leuk Res. 2005; 29: 251-3. http://dx.doi.org/10.1016/j.leukres.2005.01.012 PMid:15978946
115. Wu W, Vieira J, Fiore N, Banerjee P, Sieburg M, Rochford R, Harrington Jr, Feuer G. KSHV/HHV-8 infection of human hematopoietic progenitor (CD34+) cells: persistence of infection during hematopoiesis in vitro and in vivo.
116. Abrams DI, Chinn EK, Lewis BJ, Volberding PA, Conant MA, Townsend RM. Hematologic manifestations in homosexual men with Kaposi's sarcoma Am J Clin Pathol. 1984; 81: 13-8. PMid:6704205